Biomea Fusion Says Topline Data From Phase 1 Obesity Trial Of BMF-650 Now Expected In October, Pushed From Q3

Benzinga Newsdesk www.benzinga.com Neutral 92.5%

Neg 0% Neu 92.5% Pos 0%

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001840439/000119312526397870/bmea-20260922.htm

Comments

No comments yet. Be the first!